Business Practice

Drug pricing concerns, facility expansions and regulatory changes... What’s new for pharma in business?

Single-use biotech process equipment is already making use of technology to automate processes and the level of complexity is increasing.

Sitting Down With… Charles Gore, Executive Director, Medicines Patent Pool (MPP), Geneva, Switzerland.

Rethinking our approach to the use of energy and resources could help transform our relationship with the environment.

We only have one planet. We must play a responsible role when it comes to its care.

Can’t offer an “affordable” price? Then say goodbye to market exclusivity.

Joe Biden apparently dared say there were “great drug companies out there – except for a couple of opioid outfits.”

Sue Springett, Commercial Manager at Teknomek, explains the importance of health and safety in a solid coroporate social responsibility strategy.

Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”?

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.